
Anokion
Harnessing the power of natural immune equilibrium to develop solutions for antigen-specific immune tolerance.
Enterprise value
$200m
Company register number
CH-550.1.066.332-8
Recent deals
Authorizing premium user...
Harnessing the power of natural immune equilibrium to develop solutions for antigen-specific immune tolerance.